News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Vivek Subbiah: Our latest commentary on Pediatric AML Trials
Vivek Subbiah/LinkedIn
Jan 29, 2025, 18:53

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn about recent paper by Vivek Subbiah and Branko Cuglievan, titled “Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology” published on Nature Reviews.

Vivek Subbiah: Our latest commentary on Pediatric AML Trials

“Hot of the press.
Pleased to share our latest commentary in Nature Reviews Clinical Oncology. ‘Transforming Pediatric AML Trials: From Failing One-Size-Fits-All Methods to Precision Oncology.’ Thrilled to collaborate with my amazing colleague and friend and the brilliant Dr. Branko Cuglievan.”

Branko Cuglievan cancer Nature Reviews Clinical Oncology OncoDaily Oncology Pediatric AML Trials Vivek Subbiah
Special Coverage
Blog
Mar 1, 2025, 15:32
Publishing With Purpose - SIOP Europe's new monthly campaign
Blog
Mar 1, 2025, 15:20
Susanna Greer: The best new tool against cancer
Science
Mar 1, 2025, 15:12
Elvina Almuradova: Exercise and Colon Cancer Survival
Science
Mar 1, 2025, 15:00
Andrei Nikiforchin: What can an elevated pre-surgery CRP tell about mucinous appendix cancer prognosis?
Science
Mar 1, 2025, 14:44
Udhayvir Grewal: Impressive data for PDAC outcomes by metastatic site
Oncolibrary
Mar 1, 2025, 14:24
Overview of World Cancer Congress (WCC)
Blog
Mar 1, 2025, 14:16
Michael Sapienza: Colorectal cancer has a 91% chance of survival when caught early
Blog
Mar 1, 2025, 14:05
Roberto Grasso: New Neuropsychological Assessment and Rehabilitation Service for cancer patients
Blog
Mar 1, 2025, 13:40
Rawia Mohamed: The association between lack of response in an MSI-H patient and heterogeneous MMR status
Blog
Mar 1, 2025, 13:26
Mark Clemens: MD Anderson Cancer Center seeks a visionary Chair of Breast Medical Oncology
Blog
Mar 1, 2025, 13:01
Gertjan Rasschaert: First patient dosed worldwide today in AZUR4 at UZ Leuven
Blog
Mar 1, 2025, 12:56
Isabel Mestres: The fight for equity in healthcare isn’t easy—but it’s one we cannot afford to lose